Ogechi Ikediobi

Title(s)Resident Physician, Dermatology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination. Pediatr Dermatol. 2022 May 06. Ikediobi O, Eichenfield DZ, Barrio VR. PMID: 35522122.
      View in: PubMed   Mentions:
    2. Pharmacogenomics of Fluoropyrimidines-A Personalized Approach for Treating and Preventing Keratinocyte Carcinomas. JAMA Dermatol. 2021 03 01; 157(3):357-358. Ikediobi O. PMID: 33533896.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Pharmacogenomics of Allopurinol and Sulfamethoxazole/Trimethoprim: Case Series and Review of the Literature. J Pers Med. 2021 Jan 26; 11(2). Ikediobi O, Schneider JA. PMID: 33530463; PMCID: PMC7911847.
      View in: PubMed   Mentions:
    4. A Personalized Medicine Approach to Guide Allopurinol Use and Prevent Serious Adverse Events: Ethnicity Is Not a Proxy for Genetics. Clin Pharmacol Ther. 2021 10; 110(4):852-854. Ikediobi O. PMID: 33330976.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Mission Unify: Holistic Admissions Policies Should Include Both African American and Non-African American Blacks. Acad Med. 2020 12; 95(12):1791. Ikediobi U, Comfere N, Ikediobi O. PMID: 33234823.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women. AIDS Res Hum Retroviruses. 2016 06; 32(6):529-38. Röhrich CR, Drögemöller BI, Ikediobi O, van der Merwe L, Grobbelaar N, Wright GE, McGregor N, Warnich L. PMID: 26655325; PMCID: PMC4892230.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    7. Familial secondary hyperhidrosis associated with tumor necrosis factor-alpha inhibitor treatment. JAAD Case Rep. 2015 Nov; 1(6):418-20. Ikediobi O, Chen YC, Shinkai K. PMID: 27051797; PMCID: PMC4809394.
      View in: PubMed   Mentions: 1  
    8. Pharmacogenetics in dermatology: a patient-centered update. Int J Dermatol. 2013 Aug; 52(8):1005-12. Comfere NI, Ikediobi ON, Peters MS, el-Azhary RA, Gibson LE. PMID: 23786543.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Reactions, beliefs and concerns associated with providing hair specimens for medical research among a South African sample: a qualitative approach. Future Virol. 2012 Nov 01; 7(11):1135-1142. Coetzee B, Kagee A, Tomlinson M, Warnich L, Ikediobi O. PMID: 23646064; PMCID: PMC3640774.
      View in: PubMed   Mentions: 14  
    10. Pharmacogenomic applications in oncology. J Pharm Pract. 2012 Aug; 25(4):439-46. Walko CM, Ikediobi O. PMID: 22907843.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. Early developments in gene-expression profiling of breast tumors: potential for increasing black-white patient disparities in breast cancer outcomes? Per Med. 2011 Nov; 8(6):669-679. Odierna DH, Afable-Munsuz A, Ikediobi O, Beattie M, Knight S, Ko M, Wilson A, Ponce NA. PMID: 22190978; PMCID: PMC3242007.
      View in: PubMed   Mentions:    Fields:    
    12. Analysis of pharmacogenetic traits in two distinct South African populations. Hum Genomics. 2011 May; 5(4):265-82. Ikediobi O, Aouizerat B, Xiao Y, Gandhi M, Gebhardt S, Warnich L. PMID: 21712189; PMCID: PMC3525241.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    13. The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions. Hum Genomics. 2010 Apr; 4(4):238-49. Marques SC, Ikediobi ON. PMID: 20511137; PMCID: PMC3525209.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    14. Multifactorial regulation of E-cadherin expression: an integrative study. Mol Cancer Ther. 2010 Jan; 9(1):1-16. Reinhold WC, Reimers MA, Lorenzi P, Ho J, Shankavaram UT, Ziegler MS, Bussey KJ, Nishizuka S, Ikediobi O, Pommier YG, Weinstein JN. PMID: 20053763; PMCID: PMC2821037.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    15. Addressing the challenges of the clinical application of pharmacogenetic testing. Clin Pharmacol Ther. 2009 Jul; 86(1):28-31. Ikediobi ON, Shin J, Nussbaum RL, Phillips KA, UCSF Center for Translational and Policy Research on Personalized Medicine, Walsh JM, Ladabaum U, Marshall D. PMID: 19536122; PMCID: PMC2910521.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    16. Personalized medicine: are we there yet? Pharmacogenomics J. 2009 Apr; 9(2):85. Ikediobi ON. PMID: 18794909.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Somatic pharmacogenomics in cancer. Pharmacogenomics J. 2008 Oct; 8(5):305-14. Ikediobi ON. PMID: 18679398.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    18. In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation. Mol Cancer Ther. 2008 Jun; 7(6):1337-46. Ikediobi ON, Reimers M, Durinck S, Blower PE, Futreal AP, Stratton MR, Weinstein JN. PMID: 18524847; PMCID: PMC2705835.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    19. Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol Cancer Ther. 2006 Nov; 5(11):2606-12. Ikediobi ON, Davies H, Bignell G, Edkins S, Stevens C, O'Meara S, Santarius T, Avis T, Barthorpe S, Brackenbury L, Buck G, Butler A, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Hunter C, Jenkinson A, Jones D, Kosmidou V, Lugg R, Menzies A, Mironenko T, Parker A, Perry J, Raine K, Richardson D, Shepherd R, Small A, Smith R, Solomon H, Stephens P, Teague J, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Reinhold W, Weinstein JN, Stratton MR, Futreal PA, Wooster R. PMID: 17088437; PMCID: PMC2705832.
      View in: PubMed   Mentions: 202  Translation:HumansCells
    20. Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug. J Aerosol Med. 2002; 15(3):261-70. Shaik MS, Haynes A, McSween J, Ikediobi O, Kanikkannan N, Singh M. PMID: 12396414.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Long-circulating monensin nanoparticles for the potentiation of immunotoxin and anticancer drugs. J Pharm Pharmacol. 2001 May; 53(5):617-27. Shaik MS, Ikediobi O, Turnage VD, McSween J, Kanikkannan N, Singh M. PMID: 11370701.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    Ogechi's Networks
    Concepts (147)
    Derived automatically from this person's publications.
    Co-Authors (9)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department